| GAMPX | SPMGX | GAMPX / SPMGX | |
| Total Expense Ratio | 1.11 | 6.88 | 16% |
| Annual Report Gross Expense Ratio | 1.17 | 6.88 | 17% |
| Fund Existence | 8 years | 7 years | - |
| Gain YTD | -3.130 | 2.467 | -127% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 423M | 1.03B | 41% |
| Annual Yield % from dividends | 3.32 | 5.86 | 57% |
| Returns for 1 year | -2.41 | 2.96 | -81% |
| Returns for 3 years | 32.73 | 73.45 | 45% |
| Returns for 5 years | 106.44 | 205.46 | 52% |
| Returns for 10 years | N/A | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SGQIX | 44.85 | 0.06 | +0.13% |
| DWS International Opportunities Inst | |||
| GMVRX | 16.58 | N/A | N/A |
| Goldman Sachs Small/Mid Cap Equity R | |||
| CRQSX | 14.53 | N/A | N/A |
| Catholic Rspnsbl Invst Equity Idx Ins | |||
| VIMSX | 80.40 | -0.01 | -0.01% |
| Vanguard Mid Cap Index Investor | |||
| FPHAX | 31.27 | -0.94 | -2.92% |
| Fidelity Select Pharmaceuticals Port | |||